Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients

• Status: Unknown status
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective is to assess the effect of simvastatin on immunology, inflammatory, and coagulation responses, and mortality in elderly with pneumonia based. The primary outcome is mortality event.

The hypothesis of this study is that simvastatin therapy will reduce mortality in elderly with pneumonia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Indonesia University
• Treatments: Simvastatin

Criteria

Inclusion Criteria:

• Elderly patients with pneumonia

Exclusion Criteria:

• Severe septic condition

• Hepatic Cirrhosis

• Acute coronary disease

• Total cholesterol which is too high or too low

• In anticoagulant therapy

• In steroid therapy or other immunosuppressant therapy

• Have refused to join the study